• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Hinge Health Inc.

    2/13/26 5:25:02 PM ET
    $HNGE
    EDP Services
    Technology
    Get the next $HNGE alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Hinge Health, Inc.

    (Name of Issuer)


    Class A Common Stock, par value $0.00001 per share

    (Title of Class of Securities)


    433313103

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    433313103


    1Names of Reporting Persons

    Insight Venture Partners X, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    4,681,897.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    4,681,897.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    4,681,897.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  Rows 6, 8 and 9 include 4,681,897 shares of Class A Common Stock issuable upon the exchange of such 4,681,897 shares of Class B Common Stock for Class A Common Stock on a one-for-one basis. See Item 4(b) for further information regarding Row 11. Percentage ownership is based on 47,294,319 shares of Class A Common Stock, which is the sum of (x) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025, and (y) 9,375,164 shares of Class A Common Stock issuable upon the exchange of all shares of Class B Common Stock held by the Reporting Persons, but assuming no exchange of any other shares of Class B Common Stock.


    SCHEDULE 13G

    CUSIP No.
    433313103


    1Names of Reporting Persons

    Insight Venture Partners (Cayman) X, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    3,839,211.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    3,839,211.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    3,839,211.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.1 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  Rows 6, 8 and 9 include 3,839,211 shares of Class A Common Stock issuable upon the exchange of such 3,839,211 shares of Class B Common Stock for Class A Common Stock on a one-for-one basis. See Item 4(b) for further information regarding Row 11. Percentage ownership is based on 47,294,319 shares of Class A Common Stock, which is the sum of (x) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025, and (y) 9,375,164 shares of Class A Common Stock issuable upon the exchange of all shares of Class B Common Stock held by the Reporting Persons, but assuming no exchange of any other shares of Class B Common Stock.


    SCHEDULE 13G

    CUSIP No.
    433313103


    1Names of Reporting Persons

    Insight Venture Partners (Delaware) X, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    742,658.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    742,658.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    742,658.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    1.6 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  Rows 6, 8 and 9 include 742,658 shares of Class A Common Stock issuable upon the exchange of such 742,658 shares of Class B Common Stock for Class A Common Stock on a one-for-one basis. See Item 4(b) for further information regarding Row 11. Percentage ownership is based on 47,294,319 shares of Class A Common Stock, which is the sum of (x) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025, and (y) 9,375,164 shares of Class A Common Stock issuable upon the exchange of all shares of Class B Common Stock held by the Reporting Persons, but assuming no exchange of any other shares of Class B Common Stock.


    SCHEDULE 13G

    CUSIP No.
    433313103


    1Names of Reporting Persons

    Insight Venture Partners X (Co-Investors), LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    111,398.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    111,398.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    111,398.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.2 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  Rows 6, 8 and 9 include 111,398 shares of Class A Common Stock issuable upon the exchange of such 111,398 shares of Class B Common Stock for Class A Common Stock on a one-for-one basis. See Item 4(b) for further information regarding Row 11. Percentage ownership is based on 47,294,319 shares of Class A Common Stock, which is the sum of (x) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025, and (y) 9,375,164 shares of Class A Common Stock issuable upon the exchange of all shares of Class B Common Stock held by the Reporting Persons, but assuming no exchange of any other shares of Class B Common Stock.


    SCHEDULE 13G

    CUSIP No.
    433313103


    1Names of Reporting Persons

    Insight Venture Associates X, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    9,375,164.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    9,375,164.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    9,375,164.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    19.8 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  Rows 6, 8 and 9 include 9,375,164 shares of Class A Common Stock issuable upon the exchange of such 9,375,164 shares of Class B Common Stock for Class A Common Stock on a one-for-one basis. See Item 4(b) for further information regarding Row 11. Percentage ownership is based on 47,294,319 shares of Class A Common Stock, which is the sum of (x) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025, and (y) 9,375,164 shares of Class A Common Stock issuable upon the exchange of all shares of Class B Common Stock held by the Reporting Persons, but assuming no exchange of any other shares of Class B Common Stock.


    SCHEDULE 13G

    CUSIP No.
    433313103


    1Names of Reporting Persons

    Insight Venture Associates X, Ltd.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    9,375,164.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    9,375,164.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    9,375,164.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    19.8 %
    12Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:  Rows 6, 8 and 9 include 9,375,164 shares of Class A Common Stock issuable upon the exchange of such 9,375,164 shares of Class B Common Stock for Class A Common Stock on a one-for-one basis. See Item 4(b) for further information regarding Row 11. Percentage ownership is based on 47,294,319 shares of Class A Common Stock, which is the sum of (x) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025, and (y) 9,375,164 shares of Class A Common Stock issuable upon the exchange of all shares of Class B Common Stock held by the Reporting Persons, but assuming no exchange of any other shares of Class B Common Stock.


    SCHEDULE 13G

    CUSIP No.
    433313103


    1Names of Reporting Persons

    Insight Holdings Group, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    9,375,164.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    9,375,164.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    9,375,164.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    19.8 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  Rows 6, 8 and 9 include 9,375,164 shares of Class A Common Stock issuable upon the exchange of such 9,375,164 shares of Class B Common Stock for Class A Common Stock on a one-for-one basis. See Item 4(b) for further information regarding Row 11. Percentage ownership is based on 47,294,319 shares of Class A Common Stock, which is the sum of (x) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025, and (y) 9,375,164 shares of Class A Common Stock issuable upon the exchange of all shares of Class B Common Stock held by the Reporting Persons, but assuming no exchange of any other shares of Class B Common Stock.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Hinge Health, Inc.
    (b)Address of issuer's principal executive offices:

    455 Market Street, Suite 700, San Francisco, California, 94105
    Item 2. 
    (a)Name of person filing:

    This Amendment No. 1 to Schedule 13G is being filed by the following persons (each a "Reporting Person" and, collectively, the "Reporting Persons"): (i) Insight Venture Partners X, L.P. ("IVP X") (ii) Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), (iii) Insight Venture Partners (Delaware), L.P., ("IVP Delaware X"), (iv) Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds"), (vi) Insight Venture Associates X, L.P. ("IVA X"), Insight Venture Associates X, Ltd. ("IVA X Ltd") and (vii) Insight Holdings Group, LLC ("Holdings"). Holdings is the sole shareholder of IVA X Ltd, which is the general partner of IVA X, which is the general partner of each of the IVP X Funds (collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities.
    (b)Address or principal business office or, if none, residence:

    The address of the principal business and principal office of each of the Reporting Persons is c/o Insight Partners,1114 Avenue of the Americas, 36th Floor, New York, New York 10036.
    (c)Citizenship:

    See Item 2(a).
    (d)Title of class of securities:

    Class A Common Stock, par value $0.00001 per share
    (e)CUSIP No.:

    433313103
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    The information required by Item 4(a) is set forth in Rows 5-11 of the cover pages hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.
    (b)Percent of class:

    Based on the quotient obtained by dividing (x) the aggregate number of shares of Class A Common Stock and Class B Common Stock beneficially owned by the Reporting Person, by (y) the sum of (i) 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Form 10-Q filed on November 7, 2025, and (ii) the number of shares of Class B Common Stock beneficially owned by the Reporting Persons. The number of shares of Class B Common Stock beneficially owned by the Reporting Person(s) are treated as converted into Class A Common Stock only for the purpose of computing the percentage ownership of the Reporting Person for the purpose hereof. The Reporting Persons beneficially own an aggregate of 9,375,164 shares of Class B Common Stock, which are treated as converted into Class A Common Stock for purposes of this percent of class calculation and represents approximately 19.8% of the Class A Common Stock outstanding (calculated in accordance with the paragraph above). If all outstanding shares of Class B Common Stock (as reported in the Form 10-Q) were deemed converted into Class A Common Stock, the Reporting Persons would be deemed to beneficially own approximately 11.9% of the shares of Class A Common Stock deemed outstanding.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    The information required by Item 4(c) is set forth in Rows 5-11 of the cover pages hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.

     (ii) Shared power to vote or to direct the vote:

    The information required by Item 4(c) is set forth in Rows 5-11 of the cover pages hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.

     (iii) Sole power to dispose or to direct the disposition of:

    The information required by Item 4(c) is set forth in Rows 5-11 of the cover pages hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.

     (iv) Shared power to dispose or to direct the disposition of:

    The information required by Item 4(c) is set forth in Rows 5-11 of the cover pages hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    As the general partner of the IVP X Funds, IVA X may be deemed to beneficially own all 9,375,164 Class B Common Stock held directly by the IVP X Funds. As the general partner of IVA X, IVA Ltd may be deemed to beneficially own all 9,375,164 Class B Common Stock held by IVA X. As the sole shareholder of IVA X Ltd, Holdings may be deemed to beneficially own all 9,375,164 Class B Common Stock held by IVA X Ltd.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    The Reporting Persons are making this single, joint filing because they may be deemed to constitute a "group" within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The agreement among the Reporting Persons to file jointly in accordance with Rule 13d-1(k) of the Exchange Act is attached hereto as Exhibit 99.1. The Reporting Persons disclaim membership in a group and this report shall not be deemed an admission by any of the Reporting Persons that they are or may be members of a "group" for purposes of Rule 13d-5 or for any other purposes.
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Insight Venture Partners X, LP
     
    Signature:/s/ Andrew Prodromos
    Name/Title:Andrew Prodromos/Authorized Officer
    Date:02/13/2026
     
    Insight Venture Partners (Cayman) X, LP
     
    Signature:/s/ Andrew Prodromos
    Name/Title:Andrew Prodromos/Authorized Officer
    Date:02/13/2026
     
    Insight Venture Partners (Delaware) X, LP
     
    Signature:/s/ Andrew Prodromos
    Name/Title:Andrew Prodromos/Authorized Officer
    Date:02/13/2026
     
    Insight Venture Partners X (Co-Investors), LP
     
    Signature:/s/ Andrew Prodromos
    Name/Title:Andrew Prodromos/Authorized Officer
    Date:02/13/2026
     
    Insight Venture Associates X, L.P.
     
    Signature:/s/ Andrew Prodromos
    Name/Title:Andrew Prodromos/Authorized Officer
    Date:02/13/2026
     
    Insight Venture Associates X, Ltd.
     
    Signature:/s/ Andrew Prodromos
    Name/Title:Andrew Prodromos/Authorized Officer
    Date:02/13/2026
     
    Insight Holdings Group, LLC
     
    Signature:/s/ Andrew Prodromos
    Name/Title:Andrew Prodromos/Attorney-in-Fact
    Date:02/13/2026
    Exhibit Information

    Exhibit 99.1 Joint Filing Agreement, as required by Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended

    Get the next $HNGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HNGE

    DatePrice TargetRatingAnalyst
    1/9/2026$68.00Overweight
    Wells Fargo
    9/5/2025$56.00Neutral
    Robert W. Baird
    7/14/2025$58.00Mkt Outperform
    Citizens JMP
    6/16/2025Outperform
    William Blair
    6/16/2025$48.00Buy
    Truist
    6/16/2025$48.00Buy
    Stifel
    6/16/2025$45.00Outperform
    Raymond James
    6/16/2025$41.00Overweight
    Piper Sandler
    More analyst ratings

    $HNGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sloat Tyler

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    4/7/26 4:46:53 PM ET
    $HNGE
    EDP Services
    Technology

    SEC Form 4 filed by Mecklenburg Gabriel M.I.

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    4/2/26 8:07:27 PM ET
    $HNGE
    EDP Services
    Technology

    SEC Form 4 filed by Pursley James

    4 - Hinge Health, Inc. (0001673743) (Issuer)

    4/1/26 4:24:30 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on Hinge Health with a new price target

    Wells Fargo initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $68.00

    1/9/26 9:05:22 AM ET
    $HNGE
    EDP Services
    Technology

    Robert W. Baird initiated coverage on Hinge Health with a new price target

    Robert W. Baird initiated coverage of Hinge Health with a rating of Neutral and set a new price target of $56.00

    9/5/25 7:59:54 AM ET
    $HNGE
    EDP Services
    Technology

    Citizens JMP initiated coverage on Hinge Health with a new price target

    Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00

    7/14/25 8:51:47 AM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Hinge Health Inc.

    SCHEDULE 13G/A - Hinge Health, Inc. (0001673743) (Subject)

    3/27/26 9:30:19 AM ET
    $HNGE
    EDP Services
    Technology

    SEC Form 144 filed by Hinge Health Inc.

    144 - Hinge Health, Inc. (0001673743) (Subject)

    3/23/26 4:35:08 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health Inc. filed SEC Form 8-K: Leadership Update

    8-K - Hinge Health, Inc. (0001673743) (Filer)

    3/17/26 4:06:50 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hinge Health to announce first quarter 2026 financial results on May 5, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting wit

    4/2/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health now supports over 300 public sector organizations including 24 state governments

    Hinge Health, Inc. (NYSE:HNGE) today announced its expansion throughout the public sector, now delivering musculoskeletal (MSK) care to employees across 24 state employee health plan clients. With MSK conditions continuing to be a top healthcare cost driver, leading state governments are taking a different approach, prioritizing early intervention, accessibility, and evidence-based care that meets employees where they are. "Providing our team with a digital program that fits into their busy lives ensures they get the right care at the right time," said Karyn Williams, Program Manager at Employees' Group Insurance for the State of Wyoming. "By adding Hinge Health as a benefit for our emplo

    3/31/26 10:00:00 AM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health appoints Tyler Sloat to its board of directors

    Hinge Health, Inc. (NYSE:HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. "Tyler brings decades of deep operating experience," said Daniel Perez, Co-Founder and CEO, Hinge Health. "His track record of scaling public companies with operational rigor and financial discipline will be instrumental as we advance our mission to automate healthcare delivery." As a seasoned executive and board member, Sloat has nearly three decades of operational leadership guid

    3/17/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Leadership Updates

    Live Leadership Updates

    View All

    Hinge Health appoints Tyler Sloat to its board of directors

    Hinge Health, Inc. (NYSE:HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. "Tyler brings decades of deep operating experience," said Daniel Perez, Co-Founder and CEO, Hinge Health. "His track record of scaling public companies with operational rigor and financial discipline will be instrumental as we advance our mission to automate healthcare delivery." As a seasoned executive and board member, Sloat has nearly three decades of operational leadership guid

    3/17/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    $HNGE
    Financials

    Live finance-specific insights

    View All

    Hinge Health to announce first quarter 2026 financial results on May 5, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting wit

    4/2/26 4:05:00 PM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, st

    1/14/26 9:00:00 AM ET
    $HNGE
    EDP Services
    Technology

    Hinge Health to announce third quarter 2025 financial results on November 4, 2025

    Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting with

    10/1/25 5:00:00 PM ET
    $HNGE
    EDP Services
    Technology